Cargando…
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)
BACKGROUND: Age‐related chronic low‐grade inflammation (inflammaging) is one of the proposed mechanisms behind sarcopenia. However, findings regarding inflammatory markers in sarcopenic older adults are conflicting. This study aimed to determine the association between inflammatory markers, prevalen...
Autores principales: | Dupont, Jolan, Antonio, Leen, Dedeyne, Lenore, O'Neill, Terence W., Vanderschueren, Dirk, Rastrelli, Giulia, Maggi, Mario, Bártfai, György, Casanueva, Felipe F., Giwercman, Aleksander, Słowikowska‐Hilczer, Jolanta, Punab, Margus, Huhtaniemi, Ilpo T., Wu, Frederick C.W., Tournoy, Jos, Koppo, Katrien, Gielen, Evelien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718046/ https://www.ncbi.nlm.nih.gov/pubmed/34523822 http://dx.doi.org/10.1002/jcsm.12785 |
Ejemplares similares
-
Sarcopenia‐defining parameters, but not sarcopenia, are associated with cognitive domains in middle‐aged and older European men
por: Amini, Nadjia, et al.
Publicado: (2023) -
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
por: Anand‐Ivell, Ravinder, et al.
Publicado: (2022) -
Exercise and Nutrition for Healthy AgeiNg (ENHANce) project – effects and mechanisms of action of combined anabolic interventions to improve physical functioning in sarcopenic older adults: study protocol of a triple blinded, randomized controlled trial
por: Dedeyne, Lenore, et al.
Publicado: (2020) -
The role of omega-3 in the prevention and treatment of sarcopenia
por: Dupont, Jolan, et al.
Publicado: (2019) -
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort
por: Ivell, Richard, et al.
Publicado: (2022)